TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Autor: Quoix, Elisabeth, Lena, Hervé, Losonczy, Gyorgy, Forget, Frédéric, Chouaid, Christos, Papai, Zsolt, Gervais, Radj, Ottensmeier, Christian, Szczesna, Aleksandra, Kazarnowicz, Andrzej, Beck, Joseph T, Westeel, Virginie, Felip, Enriqueta, Debieuvre, Didier, Madroszyk, Anne, Adam, Julien, Lacoste, Gisèle, Tavernaro, Annette, Bastien, Bérangère, Halluard, Céline, Palanché, Tania, Limacher, Jean-Marc
Zdroj: In The Lancet Oncology February 2016 17(2):212-223
Databáze: ScienceDirect